Fierce Healthcare August 6, 2024
Emma Beavins

The Food and Drug Administration has announced the technical experts and industry representatives that will take part in its new Digital Health Advisory Committee (DHAC). The committee will address the use of generative AI in medical devices at its first meeting in November.

FDA announced in October 2023 that it would create a digital health advisory committee to inform FDA on considerations for digital health technologies such as AI/ML, virtual reality, wearables, digital therapeutics and remote patient monitoring. DHAC will also weigh in on issues like decentralized clinical trials, patient-generated health data, real-world data, real-world evidence and cybersecurity, the FDA’s website says.

The FDA put out an open call for technical experts on digital health technologies to apply to sit...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Digital Health, FDA, Govt Agencies, Technology
Trump names nominees to lead CDC, FDA, and his pick for surgeon general
Patient Dies in Gene Therapy Trial, But FDA Permits Neurogene to Proceed With Low Dose
New FDA Panel Weighs In on Regulating Generative AI in Healthcare
Johns Hopkins surgeon Makary is Trump’s pick to lead FDA
Trump's FDA Pick Is MedPage Today's Former Top Editor

Share This Article